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ABSTRACT
Background
Concomitant thyroid and heart disease are frequently encountered
in clinical  practice. There are many studies evaluating thyroid function in
acute critical conditions. Information on sick euthyroid in myocardial
infarction (STEMI&NSTEMI) is limited; its correlation with short and
long-term outcome is not fully known.
Methods
100 Patients admitted at ICU with diagnosis of myocardial
infarction were included in the study. Myocardial infarction was
diagnosed based on electrocardiographic changes with lab evidence of
myocardial damage. Thyroid hormone levels (TSH, fT3 ,rT3, fT4) were
measured on day 1, 4, 7, & 30. Known hypo/hyper thyroid patients,
patients on anti thyroid medications, were excluded in this study.
Subsequently patients were divided into two groups: Patients with
low fT3 and elevated rT3 (sick euthyorid)  in one group and patients with
normal fT3 and rT3 in another group. The two groups were compared in
terms of immediate &long term mortality & morbidity.
Results
Sick euthyroid was commonly seen in patients with AWMI.
ICU and hospital stay was more in sick euthyroid group. P value
was significant (<0.001). There was a delayed short term recovery in sick
euthyroid group.
Number of patients needing invasive management was (47% in
sick euthyroid  vs 18% in control group). P value was significant (<0.05).
More patients needed invasive management on follow up in sick
euthyroid group.
Markers for poor outcome such as depressed ejection fraction was
more in the sick euthyroid group compared to control group.
P value was significant <0.001.  Readmissions & mortality was more in
sick euthyroid group. Hence patients in sick euthyroid group had
increased long term morbidity.
Conclusions
Thyroid dysfunction, particularly sick euthyroid syndrome, can be
used to predict the short term & long term morbidity in STEMI &
NSTEMI patients.
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